Pfizer CEO on primary care, GLP-1 outlook and innovation timeline

Albert Bourla, Pfizer Chairman & CEO, discusses strong performance in primary care and the game-changing Metsera acquisition for GLP-1 set to launch by 2028  on 'Mornings with Maria.'

Albert Bourla, Pfizer Chairman & CEO, addresses the current state of US vaccinations and the robust growth in Pfizer's primary care business. He highlights the strategic Metsera acquisition, emphasizing its game-changing GLP-1 product which is expected to launch by 2028.